- Home
- CBLL vs JQC Comparison
CBLL vs JQC Comparison
Compare CBLL & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- JQC
- Stock Information
- Founded
- CBLL 2014
- JQC 2003
- Country
- CBLL United States
- JQC United States
- Employees
- CBLL N/A
- JQC N/A
- Industry
- CBLL
- JQC Finance Companies
- Sector
- CBLL
- JQC Finance
- Exchange
- CBLL Nasdaq
- JQC Nasdaq
- Market Cap
- CBLL 762.0M
- JQC 749.9M
- IPO Year
- CBLL 2024
- JQC N/A
- Fundamental
- Price
- CBLL $24.69
- JQC $5.52
- Analyst Decision
- CBLL Strong Buy
- JQC
- Analyst Count
- CBLL 5
- JQC 0
- Target Price
- CBLL $33.25
- JQC N/A
- AVG Volume (30 Days)
- CBLL 151.6K
- JQC 714.6K
- Earning Date
- CBLL 02-25-2025
- JQC 01-01-0001
- Dividend Yield
- CBLL N/A
- JQC 11.13%
- EPS Growth
- CBLL N/A
- JQC N/A
- EPS
- CBLL N/A
- JQC N/A
- Revenue
- CBLL $60,041,000.00
- JQC N/A
- Revenue This Year
- CBLL $44.86
- JQC N/A
- Revenue Next Year
- CBLL $26.56
- JQC N/A
- P/E Ratio
- CBLL N/A
- JQC N/A
- Revenue Growth
- CBLL 131.62
- JQC N/A
- 52 Week Low
- CBLL $18.69
- JQC $4.82
- 52 Week High
- CBLL $32.75
- JQC $5.65
- Technical
- Relative Strength Index (RSI)
- CBLL N/A
- JQC 38.29
- Support Level
- CBLL N/A
- JQC $5.47
- Resistance Level
- CBLL N/A
- JQC $5.57
- Average True Range (ATR)
- CBLL 0.00
- JQC 0.05
- MACD
- CBLL 0.00
- JQC 0.00
- Stochastic Oscillator
- CBLL 0.00
- JQC 32.14
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.